Synchronous Bilateral Male Breast Cancer: A Rare Case Report
Journal Title: The Medical Bulletin of Haseki - Year 2019, Vol 57, Issue 3
Abstract
Male breast cancer accounts for less than 1% of all breast carcinomas and 0.17 to -1.5% of all cancers seen in men. The incidence of synchronous bilateral male breast cancer has been reported to be 1.5%-2% of all male breast cancers. Although it can affect men of any age, the median age at diagnosis is 60-70 years. Herein, we report a case of bilateral/synchronous male breast cancer.
Authors and Affiliations
Muzaffer Akıncı, Zehra Keklikkıran, Mürşit Dinçer
Use of Snake Camera (Boroscope) During Percutaneous Tracheostomy
Tracheostomy is one of the oldest surgical procedures. The percutaneous dilatational tracheostomy (PDT) technique, first used by Shelden has been modified by Ciaglia. They reported that the technique facilitates the proc...
The Role of Interleukin-4 VNTR Polymorphism in Dysmenorrhea Development
Aim: Primary dysmenorrhea (PD) is among the most common gynecological diseases in young women presenting to emergency department. It has been shown that cytokines played roles in PD pathogenesis. Interleukin-4 (IL-4), a...
Effects of Smoking on Hematological Parameters and Ferritin Levels
Aim: Cigarette smoking is associated with an increased risk of cardiovascular diseases, including coronary artery disease, peripheral vascular disease, ischemic heart disease, atherosclerosis, myocardial infarction, and...
Demographic, Clinicopathological and Laboratory Features of Focal Segmental Glomerulosclerosis Patients
Aim: Focal segmental glomerulosclerosis (FSGS) is one of the common glomerulonephritis in Turkey and the world. The aim of our study was to determine demographic and clinical features and biopsy results of patients who w...
Predictive Factors Affecting Axillary Lymph Node Metastasis in Breast Cancer
Aim: The status of axillary lymph node metastasis (ALNM) at diagnosis has been considered as one of the most important prognostic factors for overall and disease-free survival in patients with breast cancer. Determinatio...